Additionally, inhibition of VEGF-C has been reported to suppress lymphangiogenesis by prostate [20, 21], pancreatic [22], breast [23–25], gastric [26], and lung cancer cells [27]. The gene discussed is VEGFC; the disease is lung carcinoma.